Novartis to sell 70.68% stake in Novartis India for 14.46 billion rupees
Apr 11, 2026
Novartis agreed to sell its 70.68% stake in Novartis India Ltd. for 14.46 billion rupees. The buyers also launched a 26% open offer at 860.84 rupees per share.
News Related to Voveran
Related coverage linked through entity extraction aliases.
Novartis Exits Indian Listed Unit With $159 Million Stake Sale
Feb 20, 2026
Novartis AG sells its entire 70.68% stake in Novartis India Ltd. for $159 million to a consortium of investors, concluding a two-year strategic review while maintaining operations through its wholly-owned Indian subsidiary.
Novartis to Exit Indian Unit With $159 Million Stake Sale to PE Consortium
Feb 20, 2026
Swiss drugmaker Novartis will sell its entire 70.68% stake in its listed Indian unit to a private equity consortium for $159 million as part of broader global restructuring. Shares of Novartis India surged nearly 20% following the announcement.
Novartis AG Sells 70.68% Stake in India Unit for ₹1,446 Crore to PE Consortium
Feb 20, 2026
Novartis AG agreed to sell its entire 70.68% stake in Novartis India to a consortium led by WaveRise Investments, ChrysCapital, and Two Infinity Partners for approximately ₹1,446 crore, triggering a mandatory open offer at ₹860.64 per share.
Novartis AG Sells 70.68% Stake in India Unit to ChrysCapital for Rs 1,446 Crore
Feb 20, 2026
Swiss pharmaceutical major Novartis AG has signed a definitive agreement to sell its entire 70.68% stake in Novartis India to a ChrysCapital-led consortium for Rs 1,446 crore, with a mandatory open offer for an additional 26% from public shareholders.